In the PT group, where the use of NDCC was more extensive, the systolic blood pressure was lower than in the ST group (121.1 ± 16.3 vs. 125.4 ± 18.0, p = 0.012) however, in the subgroup HF patients with PT, there was no significant difference in the blood systolic pressure or in the use of ACE inhibitors/sartans compared to the ST controls. Here, ACE is linked to hydrops fetalis.